i-80 Gold Corp.
For the period ended Mar 31, 2026. Filed May 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 12, 2026
IAUX$1.39-6.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Stated in thousands of United States Dollars)
| Three months endedMarch 31, | |||
|---|---|---|---|
| Note | 2026 | 2025 | |
| OPERATING ACTIVITIES | |||
| Net loss | $(78,601) | $(41,205) | |
| Adjustments | |||
| Depletion, depreciation and amortization | 5 | 950 | 743 |
| Reclamation accretion expense | 1,067 | 975 | |
| Share-based payments | 2,520 | 692 | |
| Non-cash items included in other expense | 10 | 32,970 | 17,564 |
| Loss on loan extinguishment | 14 | 7,110 | — |
| Non-cash interest expense | 5,932 | 8,204 | |
| Finance fee expense | 12 | 6,226 | — |
| Other | (73) | 157 | |
| Net change in operating assets and liabilities | 10 | (23,181) | (9,831) |
| Cash used in operating activities | $(45,080) | $(22,701) | |
| INVESTING ACTIVITIES | |||
| Capital expenditures on property, plant and equipment | (11,856) | (356) | |
| Cash used in investing activities | $(11,856) | $(356) | |
| FINANCING ACTIVITIES | |||
| Gross proceeds from 2026 Convertible Debentures | 6 | 287,500 | — |
| Gross proceeds from NSR Royalty | 7 | 225,000 | — |
| Gross proceeds from 2026 Gold Prepay | 6 | 150,000 | — |
| Principal repayment on 2023 Convertible Debentures | 6 | (67,600) | — |
| Principal repayment on Orion Convertible Loan | 6 | (49,347) | — |
| Principal repayment on Orion Gold Prepay | 6 | (22,398) | — |
| Proceeds from shares issued in equity offerings | — | 18,618 | |
| Warrant and stock option exercises | 8 | 10,201 | 8 |
| Debt and other liability issuance costs | (24,634) | (294) | |
| Other | (1,213) | (16) | |
| Cash provided by financing activities | $507,509 | $18,316 | |
| Change in cash, cash equivalents and restricted cash during the period | 450,573 | (4,741) | |
| Cash, cash equivalents and restricted cash, beginning of period | 105,263 | 59,290 | |
| Effect of exchange rate changes on cash held | (5) | (126) | |
| Cash, cash equivalents and restricted cash, end of period | $555,831 | $54,423 | |
| Reconciliation of cash, cash equivalents, and restricted cash: | |||
| Cash and cash equivalents | 513,506 | 13,475 | |
| Restricted cash and cash equivalents | 42,325 | 40,948 | |
| Total cash, cash equivalents, and restricted cash | $555,831 | $54,423 | |
Supplemental cash flow information [Note 10]
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
| Share Capital · Additional Paid-In Capital · Accumulated Deficit | ||||||
|---|---|---|---|---|---|---|
| Note · Shares · Amount · Total Equity | ||||||
| Balance as at December 31, 2024 | 409,786,956 | $606,505 | $18,977 | $(284,818) | $340,664 | |
| Issued from financing activities | 8 | 33,551,854 | 18,441 | — | — | 18,441 |
| Share-based compensation | 8 | 20,000 | 52 | 6 | — | 58 |
| Net loss | — | — | — | (41,205) | (41,205) | |
| Balance as at March 31, 2025 | 443,358,810 | $624,998 | $18,983 | $(326,023) | $317,958 | |
| Balance as at December 31, 2025 | 827,230,192 | $799,855 | $30,583 | $(483,665) | $346,773 | |
| Issued from financing activities | 8 | 11,127,290 | 18,531 | — | — | 18,531 |
| Issued on exercise of warrants | 8 | 13,603,447 | 10,295 | (771) | — | 9,524 |
| Share-based compensation | 8 | 1,520,468 | 2,558 | 111 | — | 2,669 |
| Net loss | — | — | — | (78,601) | (78,601) | |
| Balance as at March 31, 2026 | 853,481,397 | $831,239 | $29,923 | $(562,266) | $298,896 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.